Transcript Highlights:

• Um, but this is something that we are not in the business of doing investigations and clinical trials
• </c> clinical trials. That's not what we do. clinical trials. That's not what we do.
• legislation as it is involving clinical trials.<06:03:24.320><c> There</c><06:03:24.558><c> are</c><
• </c><06:03:36.480><c> Uh</c> participate in a clinical trial. Uh participate in a clinical trial.
• </c> clinical trials. clinical trials. &gt;&gt; Thank<06:06:08.160><c> you.</c> &gt;&gt; Thank you.

Committee: House Health, Human Services and Elderly Affairs

Summary: The House Committee on Health, Human Services, and Elderly Affairs heard HB 1790-FN, which would address involuntary admissions for certain individuals with a substance use disorder. Representative Lucy Weber introduced the bill for Representative Long, and the committee heard extensive testimony both in support of and in opposition to the proposal. Opponents, including John Burns of SOS Recovery and Jake Barry of New Futures, argued that involuntary commitment is not well supported by research, can retraumatize people, may increase overdose risk after release, and could undermine New Hampshire’s existing recovery and harm-reduction efforts. They emphasized that treatment should be voluntary, trauma-informed, and paired with housing, recovery supports, and other community-based services. Representative Long said he was willing to accept DHHS’s request to amend the bill into a study commission, though he expressed concern that a prior state study had not led to action. He said the commission should focus on implementation details, including where people would be placed, staffing, withdrawal management, elopement prevention, length of commitment, and aftercare. He described involuntary commitment as one tool for people with severe dangerous addictions, distinct from drug court, and said it could help avoid criminal records. Committee members asked about capacity at New Hampshire Hospital and how the proposal would work in practice. DHHS officials Katya Fox and Cynthia Pabonis testified that the bill raises major policy and fiscal concerns. They said New Hampshire’s current system has benefited from investments in naloxone, medication-assisted treatment, recovery centers, and community-based services, and that those investments have helped reduce overdose deaths. They estimated the bill would require a new 70-bed facility costing about $40 million to build and about $33.3 million annually to operate, with only a small portion offset by insurance, plus more than $600,000 in annual legal costs and additional staffing and system changes. They also said New Hampshire Hospital has 185 beds, with about 100 patients typically ready for less restrictive settings, and that housing shortages are a major bottleneck. NAMI New Hampshire also testified in opposition, saying families often want any possible treatment for loved ones but still opposed the bill. No vote or final action was taken in the hearing.

Transcript Highlights:

• We have a clinical core that supports prospective research, so those are clinical trials where patients
• So there's a small effect, but a recognizable effect that has been shown in clinical trials.
• You cannot conduct a huge clinical trial with this.
• So if we're thinking about the clinical trials, which cost a lot of money and are still legally really
• So, RCTs—there are two issues, clinical RCTs.

Summary: The Health Professions and Program Subcommittee met to receive oversight briefings on Florida’s medical marijuana program from the Department of Health’s Office of Medical Marijuana Use (OMMU) and from the University of Florida’s Consortium for Medical Marijuana Clinical Outcomes Research. OMMU Director Christopher Kimball outlined the program’s structure, including more than 900,000 active patients, nearly 7,000 caregivers, 27 MMTC licensees, 706 dispensing locations, and nine certified testing labs. He described the state’s pre-approval process for products and advertising, plain packaging requirements, seed-to-sale tracking, registry operations, and compliance efforts such as background checks, inspections, complaint investigations, and lab desk audits. He also said the Bureau of Public Health Laboratories in Jacksonville had been accredited to begin supporting testing. Members asked about telehealth, patient growth, product safety, advertising to children, inspections, and the status of MMTC licensure; Kimball said recertifications by telehealth now make up more than half of recertifications, that patient growth has slowed, and that ongoing litigation is delaying issuance of 22 new MMTC licenses. Kimball also discussed implementation of recent legislation and licensure changes, including licenses issued under HB 387 and SB 1582 to applicants from the original Pigford-related pool, with additional cure opportunities still ongoing. He said the department is monitoring diversion, inversion, and unapproved products, and that it coordinates with law enforcement when needed but does not itself have sworn authority. In response to questions, he said the department does not regulate physicians directly, but may refer concerns to the Division of Medical Quality Assurance, and that caregiver and physician participation requirements are set by statute. Members raised concerns about edibles, child access, and continued use of child-attractive branding; Kimball said the department tries to catch issues through pre-approval and enforcement, and that complaints involving children are treated as serious and investigated using available records and camera footage. Dr. Almond Winterstein then presented the consortium’s research overview. He explained that the consortium was created by statute in 2019, includes 10 universities, and is funded by annual state appropriations. He said its work includes grants, a research repository, a clinical core, outreach, and evidence synthesis, including a recent FDA-supported review of cannabis evidence. He emphasized that the current evidence base is limited and often low quality, with the strongest signals for symptom relief in PTSD-related symptoms, nausea, and some pain outcomes, but with many studies inconclusive or mixed. He also described the consortium’s use of registry data linked to Medicaid, Medicare, death, fetal death, and birth records to study safety and outcomes, including children, pregnancy, driving safety, opioid-sparing effects, and adverse events. Winterstein said adverse event reporting is sparse and likely underreported, with most reports mild but some serious events noted, and he expressed concern about use among young adults because of uncertain benefit-risk and possible effects on the developing brain. The committee discussed the need for better surveillance, more robust adverse event reporting, and the possibility of using linked data to identify harms more quickly. At the end of the meeting, the committee rose without objection.

Transcript Highlights:

• Genetic testing also plays a growing role in identifying eligibility for clinical trials and emerging
• Researchers report that people are reluctant to participate in research studies and clinical trials involving
• Researchers report that people are reluctant to participate in research studies and clinical trials involving
• genetic testing because they're concerned about how it clinical trials involving genetic testing because

Committee: Joint Joint Committee on Financial Services

Summary: The Joint Committee on Financial Services held a fully virtual public hearing after a blizzard and state emergency closed the State House and created travel and cleanup concerns. Chairs Senator Paul Feeney and Representative James Murphy opened by thanking first responders and committee staff for making the hearing possible and noted that several members attended remotely. The committee heard testimony on three bills: H.5112, An Act Prohibiting Genetic Discrimination; H.4914, An Act Relative to the Massachusetts Uniform Commercial Code; and S.2921, An Act Relative to Travel Insurance. Most of the testimony focused on H.5112. Representative Dave Rogers and his constituent Robin Biggs testified in support of H.5112, describing gaps in federal genetic nondiscrimination law that do not cover life, long-term care, or disability insurance. Biggs shared her experience as a BRCA2 mutation carrier and said genetic knowledge helped her take preventive steps, but that people fear testing because insurers may use results against them. Lindsay Jack of the ALS Association and Lisa Schlager of FORCE also supported the bill, arguing that it would encourage preventive care, research participation, and fairer underwriting without harming insurance markets. They said insurers could still use medical history and diagnoses, but not genetic test results alone. Committee members asked questions about whether insurers currently request genetic testing and how such information is used in underwriting. Testifiers said the information is routinely asked for or found in medical records, but the bill would prohibit its use in coverage decisions and would prevent insurers from requiring testing. No votes were taken. After testimony concluded and no additional witnesses came forward, the chairs closed the hearing and adjourned the meeting by unanimous voice vote.

Transcript Highlights:

• Genetic testing also plays a growing role in identifying eligibility for clinical trials and emerging
• Researchers report that people are reluctant to participate in research studies and clinical trials involving
• Researchers report that people are reluctant to participate in research studies and clinical trials involving
• genetic testing because they're concerned about how it clinical trials involving genetic testing because

Bills: H5112 , S2921 , H4914

Committee: Joint Joint Committee on Financial Services

Keywords: genetic discrimination, genetic testing, genetic information, DNA, hereditary risk, insurance underwriting, life insurance, health insurance, long-term care insurance, disability insurance, medical privacy, consumer protection, anti-discrimination, insurer regulation, Commissioner of Insurance, chapter 176D, underwriting, hereditary disease, genomics, travel insurance

Transcript Highlights:

• education and prescribing for youth seen in our primary care clinic.
• Okay, I thought it was clinics. So they were more organization.
• It's not a part or a main focus of many, if any, clinical trials that are currently going on, whereas
• trials being led by Dr.
• These are predominantly led by academic medical centers currently as part of formal clinical trials.

Committee: Joint Joint Committee on Mental Health, Substance Use and Recovery

Summary: The Joint Committee on Mental Health, Substance Use and Recovery opened its first public hearing of the 2025–26 session with remarks from the Senate and House chairs outlining the committee’s priorities. They noted recent work on addiction and recovery legislation, the ongoing youth behavioral health crisis, and that members might need to leave periodically for floor votes. The chairs explained hearing procedures, including three-minute testimony limits, written testimony deadlines, and reporting deadlines for Senate and House bills. The hearing then focused on several bills related to youth mental health, overdose prevention, and psychedelic treatment research. A major portion of the hearing centered on bills to improve youth crisis response and overdose prevention. Testimony strongly supported bills to print the 988 Suicide and Crisis Lifeline on student ID cards, with speakers from mental health organizations, crisis centers, and individuals sharing personal stories of depression, suicide attempts, and the importance of making 988 as familiar as 911. Another set of bills would require schools to stock naloxone and provide overdose prevention education. Physicians, harm reduction advocates, students, and grieving family members testified that school-based Narcan access and education could save lives, reduce stigma, and help students recognize overdoses and understand Good Samaritan protections. Senator O’Connor and Tamika Perry also testified for a bill to strengthen substance use prevention education and reduce overdose abandonment, emphasizing the need to teach students about overdose risks and the legal protections for calling 911. The committee also heard testimony on a bill to authorize a pilot program for psychedelic treatment in licensed facilities. Senator Friedman and several medical and behavioral health professionals argued the proposal was a narrow, research-based approach distinct from the broader ballot question rejected in 2024. They said the bill would allow only a small number of supervised clinics to use psychedelics for conditions such as depression, PTSD, anxiety, and substance use disorders, with data reporting and Department of Public Health oversight. Supporters described it as a cautious way to study promising treatments while avoiding unsupervised or commercialized use. Finally, the committee heard support for a bill to create a special commission and five-year strategic plan for children’s behavioral health services, with testimony that the current system is fragmented, difficult for families to navigate, and strained by workforce and funding challenges. No votes or final actions were taken during the hearing; the committee primarily received testimony and questions on the bills.

Transcript Highlights:

• Here we're looking at clinical effects on body systems.
• Of the forensic, 1,465 are incompetent-to-stand-trial commitments and 300... ...1,465 are incompetent-to-stand-trial
• To get them to the point that they can participate in trial.
• They get trained, or maybe they're getting clinical hours, and they achieve that threshold of clinical
• Somebody is found either incompetent to stand trial, et cetera.

Committee: Senate Health & Human Services

Transcript Highlights:

• trials.
• radiation trial at the Mayo Clinic.
• And only when I complete that clinical trial can I qualify for life-extending medication.
• , and he was afforded the opportunity to participate in a clinical trial with twice the amount of radiation
• trial.

Committee: House House Health & Human Services Committee of Reference

Summary: The committee began with two radiology-related bills focused on rural access and workforce shortages. HB 2049 would allow particle accelerators for cancer treatment in critical access hospitals and counties under 400,000 population under general supervision, with rural providers testifying that the change would let patients receive care closer to home while maintaining safety protocols. The bill passed on an 11-0 vote. HB 2050 updated outdated radiologic technologist statutes, revised school accreditation and clinical-hour standards, and allowed radiologist assistants to work under supervision rather than direct supervision; an amendment also added registered nurses to the list of professionals not needing an additional license to use diagnostic X-ray machines. Testimony centered on staffing shortages, national standards, and whether the change would preserve oversight. The committee adopted the amendment and passed the bill 10-2, with some members citing the need for more vetting and concern about oversight of dangerous equipment. The committee then heard HB 2082, which creates a Childhood Cancer and Rare Childhood Disease Research Commission to award grants for phase-one pediatric cancer and rare disease trials using existing license-plate funds and other sources. Parents and patients gave emotional testimony about pediatric brain cancer diagnoses, the lack of effective treatments, and the need for Arizona to support local research; the bill passed unanimously 12-0. HB 2015 required Access to cover breastfeeding and lactation services, and an amendment made the coverage subject to CMS approval. Supporters described breastfeeding as preventive care with benefits for infants and mothers, while Access said it was neutral but appreciated the amendment’s fiscal safeguard. The bill passed 12-0 as amended. Next, HB 2177 directed Access to seek CMS waivers to restore Medicaid payments for certain services provided to American Indian and Alaska Native members by IHS and tribal facilities, including dental, diagnostic, therapeutic, and preventive services. The sponsor and a Sage Memorial Hospital witness said the bill would help tribal facilities draw down federal funds and keep services local; it passed 12-0 as amended. HB 2178 required state agency chief medical officers to hold an active medical or osteopathic license and passed without opposition. HB 2179 clarified statutory definitions separating air ambulance from ground ambulance regulation, with industry testimony saying it was a cleanup measure that would avoid unintended consequences; it also passed 12-0. Finally, HB 2183 created an 11-member emergency medicine study committee to examine EMS system sustainability, rural and urban capacity, workforce burnout, and uncompensated care. Firefighters, health care advocates, and an emergency nurse practitioner supported the study as a way to gather data and make recommendations; it passed 12-0. The committee then returned to HB 2072, which establishes an optional state certification for lactation care providers under ADHS, along with rulemaking, fees, discipline, and an advisory committee; the sponsor said the credential was needed so Access could reimburse the service, and the bill was introduced for further consideration.

Transcript Highlights:

• Maybe the associations can speak to that, the defense lawyers and the trial lawyers.
• And, of course, I'm speaking on behalf of the Missouri Association of Trial Attorneys.
• In Kansas City, Children's Mercy Hospital hosts the Angelman Syndrome Clinic.
• So it's not really part of a trial, but it is sort of a... ...and it's hard to get through those trials
• It is now in phase one human trial with fantastic results.

Committee: House Emerging Issues and Professional Registration

Summary: The committee first heard House Bill 3423 from Rep. Darren Chappell, which would require judges in Missouri courts of record to file annual financial disclosure statements, bar judges from hearing cases involving people who have given them money, and extend similar disclosure rules to members of judicial nominating commissions. Chappell framed the bill as a transparency and ethics measure. Business groups supported the proposal, but judges, bar groups, and trial and defense lawyers opposed it, arguing existing judicial ethics rules already address gifts and recusals, that the bill is overly broad in covering “anything of value,” and that it could create unintended consequences, including strategic donations to force recusal and reduced public access to judicial financial disclosures. The Supreme Court’s representative said the bill should be read alongside the full Code of Judicial Conduct and offered to provide the committee with that material. No vote was taken. The committee then heard House Bill 2922 from Rep. Jeff Myers, which would align Missouri’s right-to-try law with federal law by extending access from terminal illness to debilitating conditions and by addressing the use of Schedule I drugs in that framework. Myers said the bill is intended to help ensure access to emerging treatments and has passed in various forms in prior sessions. There was no opposition testimony, and the hearing concluded without action. Next, the committee heard House Bill 2643, also from Rep. Senate, the “Hope for Missouri Patients Act,” which would expand right-to-try access for individualized treatments such as gene therapies, enzyme replacement therapies, and substrate reduction therapies for patients with rare or debilitating diseases. Supporters, including the Goldwater Institute, a parent of a child with a rare disease, and Americans for Prosperity, said the bill could help patients access customized treatments sooner and reduce red tape. The sponsor and witnesses emphasized that the bill would not require insurance coverage and is meant to help patients who cannot wait for lengthy clinical trial or FDA pathways. No opposition testimony was offered. Finally, the committee heard House Bill 3204 from Rep. Senate, which would create a tax credit to encourage private donations to prevention resource centers that work on substance misuse prevention. Supporters from prevention organizations and advocacy groups said the credit would strengthen local prevention coalitions, reduce future treatment and criminal justice costs, and stabilize funding for services such as school education, early intervention, and suicide prevention. One opponent warned that Planned Parenthood could qualify as a prevention resource center and receive tax credits, but supporters said they had no concern about that. The hearing ended with no vote or other committee action, and the committee adjourned.

Transcript Highlights:

• Mary's commitment to public safety extends beyond traditional clinical care.
• It's clinical. This is something that is not something I'm making up.

Bills: HB1411 , HB3143 , HB3144 , HB3901 , HCR1019 , HB3981 , HB4248 , HB3194 , HB3849 , HB4095 , HB4302 , HB3342 , HB3344 , HB3287 , HB3645 , HB3647 , HB3930 , HB3931 , HB1818 , HB4454 , HB4336

Keywords: True Grit Trail, Oklahoma, tourism, signage, Department of Transportation, state parks, historical sites, economic development, medical marijuana, license transfer, Oklahoma Medical Marijuana Authority, moratorium, business regulation, commercial grower licenses, licensing restrictions, agriculture, psychological autopsy, mental health, suicide prevention, state health department

Bills: HB1411 , HB3143 , HB3144 , HB3901 , HCR1019 , HB3981 , HB4248 , HB3194 , HB3849 , HB4095 , HB4302 , HB3342 , HB3344 , HB3287 , HB3645 , HB3647 , HB3930 , HB3931 , HB1818 , HB4454 , HB4336

Keywords: True Grit Trail, Oklahoma, tourism, signage, Department of Transportation, state parks, historical sites, economic development, medical marijuana, license transfer, Oklahoma Medical Marijuana Authority, moratorium, business regulation, commercial grower licenses, licensing restrictions, agriculture, psychological autopsy, mental health, suicide prevention, state health department

Transcript Highlights:

• Part of the way it works is, yeah, I'm not on the tissue bank side, I'm on the clinic side, but I can
• And they ended up coming down to our clinic.
• And they ended up coming down to our clinic.
• Many parents choose clinics, myself included, specifically because they prioritize infection control
• Those best-practice standards filter down from the medical world into the clinical practice.

Bills: SB1014 , SB1094 , SB1146 , SB1177 , SB1192 , SB1194 , SB1214 , SB1372 , SB1390 , SB1398 , SB1399 , SB1494 , SB1557 , SB1561 , SB1564 , SB1602 , SB1603 , SB1621 , SB1628 , SB1629 , SB1713 , SB1752 , SB1776 , SB1813 , SB1814 , SB1821

Committees: Senate Health and Human Services , Senate Senate Health and Human Services COR

Keywords: gender transition, gender detransition, health insurance, medical procedures, insurance claims, official documents, Arizona law, gender reassignment, civil liability, minors, medical consent, detransition, dependent children, foster care, periodic review, court hearings, child welfare, public funds, prohibition, Arizona legislation

Transcript Highlights:

• things I could mention, and we got more money into the women's health programs to expand mobile health clinics

Bills: SB1637 , SB1 , HB300 , SB2601 , SB37 , HB2011 , HB3595 , HB3071 , SB12 , HB3372 , SB457 , HB2067 , SB2337 , SB447 , SB1506 , SB1566 , SB763 , HB3556 , SB13 , SB2018 , SB331 , SB379 , HB145 , SB441 , SB2878 , HB2885 , HB2017 , HB5246 , SB8 , SB2308 , SB1540 , HB 119 , SB1405 , SB3059 , SB15 , SB568

Keywords: SB 1637, deadly conduct, Texas Penal Code, Section 22.05, firearm, gun, pointing a gun, recklessness presumption, peace officer, law enforcement, police, officer-involved shooting, use of force, justification, self-defense, defense of others, Chapter 9, criminal prosecution, Penal Code amendment, appropriations

Summary: The House met in a late-session floor session that began with prayer, pledges, quorum, and a series of excused absences and Senate messages reporting action on numerous bills, conference committee appointments, and conference reports. Members also adopted a memorial resolution honoring Mark James Hanna, a Capitol lobbyist and advocate for nurses, and a congratulatory resolution for Rishi Tarumalasetti, an eighth-grade civics bee winner from Katy. The chamber also received and recorded a parliamentary colloquy about an unusual Senate request on SB 293, with the Chair stating the House could not recede from only part of its amendments and could not suspend the rules because the bill had not been returned from the Senate. The bulk of the session was devoted to taking up conference committee reports and related procedural resolutions, especially the state budget. The House adopted a resolution allowing the SB 1 conferees to go outside the normal bounds, then adopted the SB 1 conference report on a 107-21 vote. Debate on the budget centered on public education funding, tax relief, health care, corrections pay, and judicial compensation, with supporters calling it a responsible compromise and opponents arguing it was overly expansive and insufficient on property tax relief. The House also adopted a technical correction resolution tying judicial pay increases in SB 1 to the House version of SB 293, and members discussed at length the relationship between judicial salaries and legislative pensions. The chamber then adopted a long series of conference reports on measures covering topics such as school library review and book challenges (SB 13), SNAP restrictions on sweetened drinks and candy (SB 379), hospital price transparency (SB 331), nursing home accountability (SB 457), school district personnel compensation conflicts (HB 3372), property notice rules (HB 2011), research and development tax credits (SB 2018), and several other bills affecting elections, permits, education, and criminal justice. Most reports passed by wide margins, though some drew significant opposition, especially SB 13 and SB 379. The House also granted several Senate requests for conference committees and introduced additional resolutions to suspend conferee limits on various bills as the session moved toward adjournment.

Transcript Highlights:

• trial lawyer stuff?
• Just because something is discoverable does not make it evidence at trial or relevant evidence at trial
• It turns on a light to make sure that all of the parties in a lawsuit go into trial. trial with all of
• That's why we took these to trial.
• All right, so, as a judge, a new lawsuit comes in, and it's set for trial. We set it for trial.

Bills: SB30 , SB517 , SB1313 , SB1314 , SB1316 , SB1541 , SB1698 , SB1845 , SB1860 , SB2420 , SB2429

Committee: Senate State Affairs

Keywords: gambling, criminal offenses, penalties, defense, electronic devices, tobacco advertising, youth protection, public health, criminal offense, retailer regulation, e-cigarettes, nicotine products, health, public safety, regulation, advertising restrictions, health and safety, elections, election audit, county elections

Summary: The Senate Committee on State Affairs convened to discuss several critical pieces of legislation including SB30 and SB38. Senator Betancourt introduced a committee substitute for SB38 which underwent a smooth adoption process, moving it favorably toward the Senate. The meeting featured a mix of invited testimonies where both proponents and opponents took the floor. One notable highlight included a testimony from Melissa Casey, who criticized the current legal state as prone to fraud and detrimental to both insurers and the public at large, contending that it inflated insurance costs across the board. The discussions delved deeply into the implications of the bills on judicial processes and potential insurance ramifications, with spirited debates surrounding issues of non-economic damages and jury rights. The atmosphere remained engaged as committee members heard varied perspectives on the bills, showcasing a robust democratic process. The meeting underscored the importance of public testimony in shaping legislation, ensuring that multiple voices were considered as the committee pressed on towards making decisions that affect the legal landscape of Texas.

Transcript Highlights:

• I'm a consumer attorney at Northwest Justice Project, and I run a weekly debt collection clinic in King
• She came to our debt clinic.
• Our clients are reporting clinic closures, urgent care centers shutting down, staffing shortages, and
• Ramona Brandis continued: “Miranda warnings, public trials, [and an] independent judiciary— all foreign
• Some countries permit convictions without jury trial, have convictions based on written affidavit alone

Bills: SB5962 , SB6105 , SB6203 , SB6296

Committee: Senate Law & Justice

Keywords: spring blade knives, knife legislation, weapon regulation, public safety, law enforcement, medical debt, garnishment, wage garnishment, earnings exemption, exempt wages, debt collection, consumer debt, student loan debt, private student loans, disposable earnings, minimum wage, writ of garnishment, exemption claim, judgment debtor, creditor

Transcript Highlights:

• Education Coordinating Board on the feasibility of implementing a statewide system for coordinating clinical
• continue to struggle to increase graduation rates, which is due to a lack of faculty and lack of clinical
• Coordinating Board to determine the feasibility of developing regional portals to assist in reserving clinical

Bills: HJR98 , HJR8 , HJR133 , HB23 , HB33 , HB144 , HB 109 , HB 103 , HB148 , HB3809 , HB1686 , HB2217 , HB2156 , HB220 , HB2421 , HB2363 , HB3773 , HB421 , HB2584 , HB2615 , HB2455 , HB3711 , HB2559 , HB3747 , HB2775 , HB2886 , HB3126 , HB3666 , HB3595 , HB3260 , HB3506 , HB1638 , HB3376 , HB3826 , HB3628 , HB1349 , HB3770 , HB1831 , HB1762 , HB2614 , HB3113 , HB267 , HB322 , HB431 , HB869 , HB 1203 , HB 1201 , HB 1244 , HB1875 , HB1950 , HB2152 , HB2290 , HB2341 , HB2436 , HB2809 , HB2856 , HB3012 , HB2954 , HCR56 , HCR102 , HB 107 , HB1587 , HB3684 , HB658 , HJR99 , HB1399 , HJR5 , HJR2 , HJR6 , HJR31 , HB1971 , SJR3 , HB1775 , HJR72 , HB502 , HB3109 , HJR98 , HJR8 , HJR133 , HB 118 , HB388 , HB 114 , HB205 , HB2789 , HB2791 , HB499 , HB2960 , HB3163 , HB3135 , HB2427 , HB1618 , HB1672 , HB1722 , HB1338 , HB787 , HB2618 , HB879 , HB 1126 , HB4134 , HB3513 , HB718 , HB1536 , HB1445 , HB1640 , HB1893 , HB1734 , HB3229 , HB3306 , HB 1276 , HB3272 , HB3276 , HB3516 , HB4145 , HB1585 , HB4810 , HB2989 , HB2558 , HB3014 , HB2742 , HB1695 , HB23 , HB33 , HB144 , HB 109 , HB 103 , HB148 , HB3809 , HB1686 , HB2217 , HB2156 , HB220 , HB2421 , HB2363 , HB3773 , HB421 , HB2584 , HB2615 , HB2455 , HB3711 , HB2559 , HB3747 , HB2775 , HB2886 , HB3126 , HB3666 , HB3595 , HB3260 , HB3506 , HB1638 , HB3376 , HB3826 , HB3628 , HB1349 , HB3770 , HB1831 , HB1762 , HB2614 , HB3113 , HB267 , HB322 , HB431 , HB869 , HB 1203 , HB 1201 , HB 1244 , HB1875 , HB1950 , HB2152 , HB2290 , HB2341 , HB2436 , HB2809 , HB2856 , HB3012 , HB2954 , HCR56 , HCR102

Keywords: Article V, federal government, fiscal restraints, constitutional amendment, term limits, nuclear energy, electric generation, funding, Texas nuclear development fund, advanced reactors, HJR 133, Texas constitutional amendment, ad valorem tax, property tax exemption, homestead exemption, surviving spouse, veteran, veterans benefits, service-connected death, presumed service-connected condition

Transcript Highlights:

• There's no speedy trial. There's no demand I can be made for it.
• My professional background includes 17 years of clinical practice, with 16 of those years working with
• My professional background includes 17 years of clinical practice, with 16 of those years working with
• Treating these diagnoses as fixed legal labels misrepresents clinical reality and undermines accurate
• if a trial even happens, because usually they just come back and get dismissed for time served.

Committee: Senate Criminal Justice

Transcript Highlights:

• Trial law and how many are board certified in health law.
• There’s a trial de novo appeal.
• Oh, I'm in trial.
• I want to say a brief thing about trials.
• I teach legal aid and I teach a law school clinic.

Bills: HB32 , HB15 , HB171 , HB421 , HB581 , HB644 , HB745 , HB349 , HB917 , HB204 , HB923 , HB15 , HB171 , HB204

Committee: House Judiciary & Civil Jurisprudence

Keywords: eviction, landlord rights, tenant rights, justice court, property law, court procedures, chemical dependency, court-ordered treatment, mental health, health care, treatment facility, juvenile justice, criminal justice reform, deep fake, digital impersonation, age verification, private cause of action, explicit content, consumer protection, HB 581

Transcript Highlights:

• trials and scientific data when evaluating technologies.
• All valid clinical trials and scientific data when evaluating technologies and making benefit decisions
• I am a speech-language pathologist working with special all valid clinical trials and scientific data
• and the Madison Clinic at Harborview Medical Center.
• And we also work with Seattle Roots and two community clinics, Country Doctor Community Clinic and Carolyn

Summary: The Senate Health and Long-Term Care Committee held a hearing on several bills. SB 5904 would prohibit non-human entities from using nursing titles; the sponsor and nursing groups said it is meant to increase transparency around AI and ensure patients know when they are interacting with a real nurse. SB 5915 would change Health Technology Assessment Program review criteria and timelines, with supporters arguing it would better account for Medicare coverage and national guidelines, especially for rare and life-threatening conditions. SB 6025 would update the definition of fetal death to allow gestational age to be determined by the best clinically accurate method rather than last menstrual period, and medical professionals and the sponsor said this would reduce emotional, financial, and legal burdens on grieving families. SB 5933 would require near real-time sharing of overdose data into ODMAP; public health, local government, and recovery advocates said it would improve overdose response, while one witness asked that poison center data be included and clarified separately. SB 5990 would allow APRNs and physician assistants to serve as local health officers in counties under 100,000 population; rural county officials supported the added flexibility, while public health groups and naturopathic physicians raised concerns about qualifications and asked that naturopathic doctors be included as well. SB 5981 would restrict drug manufacturers from limiting 340B drug access through contract pharmacies or requiring data as a condition of discounts; safety-net hospitals, community health centers, pharmacies, and patients said it protects access and reinvestment in care, while manufacturers, employer groups, and industry representatives argued it increases costs, lacks transparency, and may not ensure savings reach patients. No votes or final committee actions were taken in the transcript; each bill was heard and testimony was closed. Sign-in counts were reported for several bills, including strong pro support for SB 5904, SB 5915, SB 5933, and SB 5981, and mixed or substantial opposition on SB 6025 and SB 5990.

Transcript Highlights:

• The first clinical trial for my wife's first drug, if you are familiar, the first round clinical trials
• </c><03:39:57.920><c> are</c> clinical trials for cancer drugs are clinical trials for cancer drugs are
• </c><03:40:09.439><c> only</c> those clinical trials is that you only those clinical trials is that you
• To control clinical trials would permit.
• </c> control clinical trials. control clinical trials.

Committee: House Judiciary

Transcript Highlights:

• c> with</c> clinical trials, balancing that with clinical trials, balancing that with possible<05:34:
• </c> um where we did conduct clinical trials. um where we did conduct clinical trials.
• ><c> even</c><06:03:46.718><c> the</c> conducting clinical trials, even the conducting clinical trials
• </c><06:04:59.440><c> otherwise</c> clinical trial that they would otherwise clinical trial that they
• </c> clinical trials. clinical trials. &gt;&gt; Thank<06:06:08.160><c> you.</c> &gt;&gt; Thank you.

Committee: House Health, Human Services and Elderly Affairs